Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 6/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.53 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | BAX | Q07812 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.48 |
| ▸ | CETP | P11597 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.45 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27862141 | 0.90 | KIF11 (0.47) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| SCHEMBL168125 | 0.90 | KIF11 (0.47) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| SCHEMBL28780452 | 0.90 | EPHX2 (0.50) | LTA4HTSHREPHX2NR3C1SLC6A2 | |
| SCHEMBL5239240 | 0.90 | LTA4H (0.47) | LTA4HTSHREPHX2NR3C1SLC6A2 | |
| SCHEMBL29087324 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| Fluoride SCHEMBL28371495 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| Hydrogen Sulfide SCHEMBL27539287 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| Ammonia Solution, Strong SCHEMBL2163079 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| SCHEMBL4036809 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 | |
| Water SCHEMBL27610464 | 0.87 | KIF11 (0.46) | LTA4HTSHREPHX2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100332-B | Preparation method and application of dumbbell type fluorine-containing polyphosphazene modified halloysite nanotube | 厦门大学 | 2021-06-01 | — | — | CN | claimed |
| CN-111018808-A | Fluorine-containing epoxy resin, composite material thereof and preparation method | 长春长光宇航复合材料有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-109749122-B | Hydrophobic ring cross-linked polyphosphazene composite sponge and preparation method and application thereof | 中国石油大学(华东) | 2021-10-08 | — | — | CN | disclosed |
| CN-112689633-A | For inhibiting Nav1.8 pyridine carboxamide Compounds | 利伯研究所公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-111018808-A | Fluorine-containing epoxy resin, composite material thereof and preparation method | 长春长光宇航复合材料有限公司 | 2020-04-17 | — | — | CN | disclosed |
| EP-2871180-B1 | 2-AMINONICOTINIC ACID ESTER DERIVATIVE AND BACTERICIDE CONTAINING SAME AS ACTIVE INGREDIENT | AGRO KANESHO CO LTD (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20100099663-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-04-22 | — | — | US | disclosed |
| US-20100099663-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-04-22 | — | — | US | disclosed |
| US-20100099663-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-04-22 | — | — | US | disclosed |
| EP-1763515-B1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-03-12 | — | — | EP | disclosed |
| EP-1763515-B1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2008-03-12 | — | — | EP | disclosed |
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
| EP-1763515-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006002764-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006002764-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099663-A1 | 4-TRIFLUOROMETHOXYPHENOXYBENZOL-4'-SULFONIC ACIDS, METHOD FOR THE PRODUCTION AND USE THEREOF IN MEDICAMENTS | XDH, CYP4X1, CYP4A11 | LTA4H 2271/4885TSHR 1172/4885EPHX2 2313/4885 |
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | CYP4X1, AFF1, BPGM | LTA4H 3470/4885TSHR 1416/4885EPHX2 3337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.